Marlex Pharmaceuticals, Inc. Recalls

Overview of recall records associated with Marlex Pharmaceuticals, Inc., including dates, categories and classifications where available.

2recall records

Sep 13, 2023latest record date

Sep 13, 2023earliest record date

Recall history in this database

Classification mix: Class II: 1, Class I: 1.

DrugSep 13, 2023

Marlex Pharmaceuticals Digoxin Tablets, USP 0.25mg, 100-count bottles recall — FDA D-1170-2023

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP…

Class IIFDA: TerminatedMarlex Pharmaceuticals, Inc.

DrugSep 13, 2023

Marlex Pharmaceuticals Digoxin Tablets, USP 0.125mg, 100-count bottles recall — FDA D-1169-2023

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP…

Class IFDA: TerminatedMarlex Pharmaceuticals, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies Marlex Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.